Nuwellis Inc reports results for the quarter ended December 31 - Earnings Summary

• Nuwellis Inc NUWE.OQ reported a quarterly adjusted loss of 70 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-54.60. The mean expectation of two analysts for the quarter was for a loss of 43 cents per share.

• Revenue fell 9% to $2.32 million from a year ago; analysts expected $2.46 million.

• Nuwellis Inc's reported EPS for the quarter was a loss of 44 cents​.

• The company reported a quarterly loss of $1.47 million.

• Nuwellis Inc shares had risen by 13.5% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Nuwellis Inc is $16.00

This summary was machine generated from LSEG data March 11 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)